CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Material agreement · Bylaws or fiscal year change
- 4 Option exercise Chief Medical Officer acquired 3,500 shares (option exercise)
- 4 Option exercise Chairman & CEO acquired 8,125 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 4 Open-market buy Chairman & CEO bought 10,000 shares at $0.44 ($4,372)
- 4 Open-market buy Principal Financial Officer bought 10,000 shares at $0.44 ($4,350)
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.45 ($4,499)
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 10 of 26 · 511 filings